Search Results - "Ardèvol, Mercè"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients by Saludes, Verónica, Bascuñana, Elisabet, Jordana-Lluch, Elena, Casanovas, Sònia, Ardèvol, Mercè, Soler, Esther, Planas, Ramón, Ausina, Vicente, Martró, Elisa

    Published in PloS one (28-08-2013)
    “…Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual therapy),…”
    Get full text
    Journal Article
  3. 3

    Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors by Saludes, Verónica, Bracho, Maria Alma, Valero, Oliver, Ardèvol, Mercè, Planas, Ramón, González-Candelas, Fernando, Ausina, Vicente, Martró, Elisa

    Published in PloS one (30-11-2010)
    “…Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy -especially among genotype 1 infected patients-, is costly, and involves…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Relevance of Baseline Viral Genetic Heterogeneity and Host Factors for Treatment Outcome Prediction in Hepatitis C Virus 1b-Infected Patients: e72600 by Saludes, Veronica, Bascunana, Elisabet, Jordana-Lluch, Elena, Casanovas, Sonia, Ardevol, Merce, Soler, Esther, Planas, Ramon, Ausina, Vicente, Martro, Elisa

    Published in PloS one (01-08-2013)
    “…Background Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual…”
    Get full text
    Journal Article